Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community-Reference-Cited by-同舟云学术

Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community

Published:2019-06 Issue:6 Volume:63 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Potron Anaïs¹²³^ORCID,Hocquet Didier²⁴⁵,Triponney Pauline³,Plésiat Patrick¹²³,Bertrand Xavier²⁴,Valot Benoit²

Affiliation:

1. Laboratoire de Bactériologie, Centre Hospitalier Universitaire, Besançon, France

2. UMR6249 CNRS Chrono-Environnement, Université de Bourgogne Franche-Comté, Besançon, France

3. Centre National de Référence de la résistance aux antibiotiques, Besançon, France

4. Laboratoire d’Hygiène Hospitalière, Centre Hospitalier Universitaire, Besançon, France

5. Centre de Ressources Biologiques–Filière Microbiologique de Besançon, Centre Hospitalier Universitaire, Besançon, France

Abstract

Nineteen Proteus mirabilis isolates producing the carbapenemase OXA-23 were recovered over a 2-year period in 19 French hospitalized patients, of whom 12 had community onset infections. The isolates exhibited a slightly reduced susceptibility to carbapenems.

Funder

Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche

Ministère des Solidarités et de la Santé

Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00191-19

Reference17 articles.

1. The global epidemiology of carbapenemase-producing Enterobacteriaceae